• Shuffle
    Toggle On
    Toggle Off
  • Alphabetize
    Toggle On
    Toggle Off
  • Front First
    Toggle On
    Toggle Off
  • Both Sides
    Toggle On
    Toggle Off
  • Read
    Toggle On
    Toggle Off
Reading...
Front

Card Range To Study

through

image

Play button

image

Play button

image

Progress

1/19

Click to flip

Use LEFT and RIGHT arrow keys to navigate between flashcards;

Use UP and DOWN arrow keys to flip the card;

H to show hint;

A reads text to speech;

19 Cards in this Set

  • Front
  • Back

Type 1 Adverse Reaction

Predictable

Type 2 Adverse Reaction

Not predictable

Pharmacokinetic genetic polymorphism affects:

Absorption


Metabolism


Disposition


Excretion

Pharmacodynamic genetic polymorphism affects:

Receptors


Ion channels


Enzymes


Immune system

Lack of metabolism

Increased plasma concentrations


Exaggerated pharmacological responses

Lack of metabolic pathway

Compound bioactivated by different enzyme

Lack of detoxification pathway

Enhanced toxicity

Lack of bioactivation pathway

Poor metabolisers at less risk

Increased protein expression or catalytic activity

Increase in the formation of toxic metabolites

Lack of detoxification:




Suxamethonium

-Used for muscle relaxation during surgery


-Effects last 2-6 minutes


-Hydrolysed rapidly by plasma esterases


(pseudocholinesterase, butyrylcholinesterase)


-Reduced activity in certain patients


--> results in prolonged muscle paralysis and apnea

Lack of detoxification:




6-Mercaptopurine

-Gets S-methylated by thiopurine methyl transferase (TPMT)


-Low TPMT activity = high risk of haematopoietic toxicity


-Due to accumulation of thioguanine nucleotides in haematopoietic tissues


-Therapy: 10-15 fold reduction in dose

Lack of detoxification:




Perhexiline

-Anti-angina drug


-Cationic, amphiphilic


-Metabolised by CYP2D6


-If not metabolised, can accumulate in lysosomes


-Results in hepatotoxicity and neuropathy

Genetic Profiling

Understanding the polymorphisms that dictate how our body deals with a particular drug means we can tailor the drugs we take and dosage for optimal effect

Penicillin

-A very diverse range of reactions


-Common


nausea, diarrhoea, hairy tongue


-Infrequent


neuropathy, nephropathy, haemolytic anemia, thrombocytopenia


-Hypersensitive reactions


anaphylaxis, skin eruptions, laryngeal oedema

Ethanol

-Acts at GABA receptors


-Drinking with sedatives, hypnotics and some antihistamines can have additive effects


-Too much sedation or coma and death

GABA, GABA, GABA, GABA, GABA....

...death.

Warfarin

-Narrow therapeutic index


-Cimetidine inhibits warfarin metabolism


--> blood concentrations of warfarin increased to toxic levels

Terfenadine

-Metabolised by CYP to fexofenadine


-DEATH with ketoconazole (inhibits CYP3A4)


--> Increased plasma concentrations



-Interferes with cardiac slow K+ channel, prolonging QT interval and quinidine-like effects on heart

Baycol/Lipobay



-Statin, cholesterol lowering drug


-More frequent deaths from rhabdomyolysis than other statins, so was recalled



-Major financial impact on company, they had to cut jobs and drug unit was split in two